Silence Therapeutics plc
Develops RNAi therapies that silence disease genes for rare and underserved conditions.
SLN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US82686Q1013
- LEI:
- Country:
- United States of America
- Address:
- 12 HAMMERSMITH GROVE, LONDON
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Silence Therapeutics plc is a clinical-stage biotechnology company pioneering the design and development of novel medicines based on short-interfering RNA (siRNA). The company utilizes its proprietary RNA interference (RNAi) technology platform to create precision-engineered therapies that silence the expression of specific, disease-causing genes. Silence Therapeutics focuses on advancing a new generation of medicines for patients with rare diseases and other conditions that have limited or inadequate treatment options. Its mission is to transform lives by developing therapies that address the underlying cause of disease at a genetic level.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Silence Therapeutics plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Silence Therapeutics plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Silence Therapeutics plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
